Thus, we consider that our data on the normal levels of CD4 + CD25 + Foxp3 + Treg cells in the T2DM patients included in this study add valuable information to an interesting point that, to date, remains controversial. This evidence concerns the gene CD4 and type 2 diabetes mellitus.